³Ô¹ÏÍøÕ¾

Latest pharmaceuticals News | Page 8

Growing gains in black rice and hemp
Recce Pharmaceuticals announces appointment of executive chairman
Guilty plea from Ego Pharmaceuticals on unsubstantiated SPF 50+ claims
Serendipitous backyard experiment shines light on producing polymers
Ashurst expands EMEA competition offering with hire of new partner in Brussels
Cell size regulates molecular separation
Ms Allegra Spender MP, Member for Wentworth, to join Pharmacy Connect Saturday breakfast panel
Are Costly New Prescription Drugs Worth Price?
Starpharma announces new research agreement for DEP drug delivery platform
New national lab boosts Australia’s vaccine and drug sovereign capability
Cancer immunotherapy in tablet step closer thanks to CUREator grant
Telix and UQ-led consortium awarded Australian Research Council grant
AusBiotech 2022 programme features top industry experts
Authorisation request for proposed settlement between pharmaceutical companies withdrawn
Researchers cook up new recipe for Pretzel-shaped peptides
Neurofeedback could be answer for 2.5 M Australians suffering from childhood trauma
Nominations open to recognise sector leaders
Patent filings increase in new intellectual property report
Ultomiris recommended for approval in EU by CHMP for treatment of adults with generalised myasthenia gravis
New Zealand Company Develops Unique Technology to Produce World Class Marine Collagen at Over 90% Purity
UQ research recognised in national biomedical incubator
Botanix Pharmaceuticals accelerates filing of NDA
Precision Pharmaceuticals Pty Ltd fined and directed to cease alleged unlawful advertising of nicotine vaping products
Telix and RefleXion expand partnership for prostate cancer treatment
Regeneus chief executive makes off-market investment in company
Macquarie tops 2022 Institutional Investor Asia Pacific Regional/Local Broker Rankings
Botanix acquires rights to new dermatology product
Kynd Stress Relief Tablets
Join our next Medical Research Future Fund webinar
Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial
Neuren receives ethics approval for Angelman Phase 2 trial
Approval for Neuren Pharmaceuticals’ Phase 2 trial in Angelman syndrome
Positive late-stage trial results for Neuren Pharmaceuticals’ trofinetide
TGA approves Telix Pharmaceuticals’ Illuccix for prostate cancer
Over 80% of GP’s Believe Reducing Needle Fear Could Help Boost Vaccination Rates